![Ian Abercrombie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ian Abercrombie
Algemeen Directeur bij MedAnnex Ltd.
Profiel
Ian Abercrombie is currently the Chief Executive Officer at MedAnnex Ltd.
He previously worked as a Program Director at Bioenvision, Inc., a Principal at Johnson & Johnson and the Public Health Institute, and as the Chief Operating Officer at NuCana Plc.
Actieve functies van Ian Abercrombie
Bedrijven | Functie | Begin |
---|---|---|
MedAnnex Ltd.
![]() MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Algemeen Directeur | 01-07-2019 |
Eerdere bekende functies van Ian Abercrombie
Bedrijven | Functie | Einde |
---|---|---|
NUCANA PLC | Operationeel Directeur | - |
JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Public Health Institute
![]() Public Health Institute Miscellaneous Commercial ServicesCommercial Services Public Health Institute is a non profit organization that promotes research, leadership, and partnerships. It focuses on alcohol, tobacco, drugs and mental health, capacity building, chronic disease prevention, communicable disease prevention, disabilities, environmental health, public health systems, and women, youth, and children's health. The company was founded in 1964 and is headquartered in Oakland, CA. | Corporate Officer/Principal | - |
Bioenvision, Inc.
![]() Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
NUCANA PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Bioenvision, Inc.
![]() Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
Public Health Institute
![]() Public Health Institute Miscellaneous Commercial ServicesCommercial Services Public Health Institute is a non profit organization that promotes research, leadership, and partnerships. It focuses on alcohol, tobacco, drugs and mental health, capacity building, chronic disease prevention, communicable disease prevention, disabilities, environmental health, public health systems, and women, youth, and children's health. The company was founded in 1964 and is headquartered in Oakland, CA. | Commercial Services |
MedAnnex Ltd.
![]() MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |